Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1989 1
1990 1
1992 1
1994 1
1996 1
1997 3
1998 2
1999 4
2000 2
2001 2
2002 1
2004 1
2007 1
2008 3
2009 2
2010 3
2011 4
2012 4
2013 3
2014 6
2015 7
2016 2
2017 5
2018 5
2019 4
2020 16
2021 15
2022 13
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab in Membranous Nephropathy.
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, van den Hoogen MWF, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Mayer G, Maas R, Muto M, Moiseev S, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Schönermarck U, Segelmark M, Smith L, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: alberici f. Kidney Int Rep. 2021 Jan 13;6(4):881-893. doi: 10.1016/j.ekir.2020.12.035. eCollection 2021 Apr. Kidney Int Rep. 2021. PMID: 33912740 Free PMC article. Review.
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: alberici f. Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15. Autoimmun Rev. 2020. PMID: 32942039 Free article. Review.
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, Schiavon F, Neumann T, Lopalco G, Novikov P, Baldini C, Lombardi C, Berti A, Alberici F, Folci M, Negrini S, Sinico RA, Quartuccio L, Lunardi C, Parronchi P, Moosig F, Espígol-Frigolé G, Schroeder J, Kernder AL, Monti S, Silvagni E, Crimi C, Cinetto F, Fraticelli P, Roccatello D, Vacca A, Mohammad AJ, Hellmich B, Samson M, Bargagli E, Cohen Tervaert JW, Ribi C, Fiori D, Bello F, Fagni F, Moroni L, Ramirez GA, Nasser M, Marvisi C, Toniati P, Firinu D, Padoan R, Egan A, Seeliger B, Iannone F, Salvarani C, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Bettiol A, et al. Among authors: alberici f. Arthritis Rheumatol. 2022 Feb;74(2):295-306. doi: 10.1002/art.41943. Epub 2021 Dec 30. Arthritis Rheumatol. 2022. PMID: 34347947 Free PMC article.
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.
Scolari F, Delbarba E, Santoro D, Gesualdo L, Pani A, Dallera N, Mani LY, Santostefano M, Feriozzi S, Quaglia M, Boscutti G, Ferrantelli A, Marcantoni C, Passerini P, Magistroni R, Alberici F, Ghiggeri GM, Ponticelli C, Ravani P; RI-CYCLO Investigators. Scolari F, et al. Among authors: alberici f. J Am Soc Nephrol. 2021 Apr;32(4):972-982. doi: 10.1681/ASN.2020071091. Epub 2021 Mar 1. J Am Soc Nephrol. 2021. PMID: 33649098 Free PMC article.
Update on ANCA-associated vasculitis: from biomarkers to therapy.
Tedesco M, Gallieni M, Pellegata F, Cozzolino M, Alberici F. Tedesco M, et al. Among authors: alberici f. J Nephrol. 2019 Dec;32(6):871-882. doi: 10.1007/s40620-019-00628-9. Epub 2019 Jul 12. J Nephrol. 2019. PMID: 31301058 Review.
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia.
Scolari F, Alberici F, Mescia F, Delbarba E, Trujillo H, Praga M, Ponticelli C. Scolari F, et al. Among authors: alberici f. Front Immunol. 2022 Mar 1;13:789713. doi: 10.3389/fimmu.2022.789713. eCollection 2022. Front Immunol. 2022. PMID: 35300332 Free PMC article. Review.
Editorial: "Toward Precision Medicine in Vasculitis".
Alberici F, Emmi G, Kronbichler A. Alberici F, et al. Front Immunol. 2020 Nov 17;11:616221. doi: 10.3389/fimmu.2020.616221. eCollection 2020. Front Immunol. 2020. PMID: 33281833 Free PMC article. No abstract available.
The Authors Reply.
Alberici F, Delbarba E, Scolari F. Alberici F, et al. Kidney Int Rep. 2020 Jun 17;5(8):1376. doi: 10.1016/j.ekir.2020.06.005. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32775846 Free PMC article. No abstract available.
99 results